Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21392343 | 0.77 | HSD11B1 (0.46) | HSD11B1EPHX1EPHX2FKBP1A | |
| SCHEMBL8399505 | 0.77 | HSD11B1 (0.46) | HSD11B1EPHX1EPHX2FKBP1A | |
| SCHEMBL418793 | 0.76 | HSD11B1 (0.44) | HSD11B1EPHX1ALDH1A1TSHREPHX2 | |
| SCHEMBL5391245 | 0.75 | ATM (0.46) | ALDH1A1TSHR | |
| Ethane SCHEMBL27484858 | 0.74 | HSD11B1 (0.43) | HSD11B1EPHX1ALDH1A1TSHREPHX2 | |
| SCHEMBL7988293 | 0.73 | HSD11B1 (0.42) | HSD11B1EPHX1EPHX2FKBP1A | |
| SCHEMBL24361096 | 0.72 | HSD11B1 (0.48) | HSD11B1EPHX1EPHX2FKBP1A | |
| SCHEMBL7927543 | 0.72 | HSD11B1 (0.48) | HSD11B1EPHX1EPHX2FKBP1A | |
| SCHEMBL5008276 | 0.71 | HSD11B1 (0.45) | HSD11B1EPHX1EPHX2FKBP1A | |
| SCHEMBL2475662 | 0.71 | HSD11B1 (0.41) | HSD11B1EPHX1EPHX2FKBP1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2328987-B1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | Henkel IP & Holding GmbH (DE) | 2018-02-21 | — | — | EP | claimed |
| CN-102369252-B | Transferable curable non-liquid films on release substrates | LOCTITE R & D LTD | 2015-03-11 | — | — | CN | claimed |
| US-8425999-B2 | Transferable curable non-liquid film on a release substrate | HENKEL IRELAND LIMITED (DE) | 2013-04-23 | — | — | US | claimed |
| CN-102369252-A | Transferable curable non-liquid films on release substrates | LOCTITE R & D LTD | 2012-03-07 | — | — | CN | claimed |
| US-20110151243-A1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | LOCTITE (R&D) LIMITED (IE) | 2011-06-23 | — | — | US | claimed |
| EP-2328987-A1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | Loctite (R & D) Limited (IE) | 2011-06-08 | — | — | EP | claimed |
| WO-2010023229-A1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | LOCTITE (R&D) LIMITED (IE) | 2010-03-04 | — | — | WO | claimed |
| US-20260115350-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | CHEMENCE MEDICAL, INC. (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260034263-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | CHEMENCE MEDICAL, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| EP-4608461-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | Chemence Medical, Inc. (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-4608462-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | Chemence Medical, Inc. (US) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024092049-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | CHEMENCE MEDICAL, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2024092036-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | CHEMENCE MEDICAL, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2014131650-A1 | HOT MELT ADHESIVE COMPRISING CYANOACRYLATE CURING COMPOUNDS | HENKEL AG & CO. KGAA (DE) | 2014-09-04 | — | — | WO | disclosed |
| US-20140238603-A1 | HOT MELT ADHESIVE COMPRISING CYANOACRYLATE CURING COMPOUNDS | HENKEL AG & CO. KGAA (DE) | 2014-08-28 | — | — | US | disclosed |
| US-8425999-B2 | Transferable curable non-liquid film on a release substrate | HENKEL IRELAND LIMITED (DE) | 2013-04-23 | — | — | US | disclosed |
| CN-102369252-A | Transferable curable non-liquid films on release substrates | LOCTITE R & D LTD | 2012-03-07 | — | — | CN | disclosed |
| US-20110151243-A1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | LOCTITE (R&D) LIMITED (IE) | 2011-06-23 | — | — | US | disclosed |
| EP-2328987-A1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | Loctite (R & D) Limited (IE) | 2011-06-08 | — | — | EP | disclosed |
| WO-2010023229-A1 | TRANSFERABLE CURABLE NON-LIQUID FILM ON A RELEASE SUBSTRATE | LOCTITE (R&D) LIMITED (IE) | 2010-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115350-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | CUTA, ICAM1, CLSPN | HSD11B1 3256/4885EPHX1 2080/4885ALDH1A1 795/4885 |
| US-20260034263-A1 | ANTIMICROBIAL CYANOACRYLATE FORMULATIONS | CUTA, ICAM1, CLSPN | HSD11B1 3095/4885EPHX1 2660/4885ALDH1A1 847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.